---
title: "With €30 million, Biolevate wants to make AI a compliance tool for laboratories — Marsanne Studio AI watch"
description: "Biolevate raises €30 million to roll out its regulatory knowledge management AI to pharmaceutical laboratories."
url: "https://marsanne.studio/en/ai-watch/with-30-million-biolevate-wants-to-make-ai-a-compliance-tool-for-6b7de1/"
lang: "en"
---

[Marsanne Studio](https://marsanne.studio/en/)

[← Back to home](https://marsanne.studio/en/ai-watch)

[← The AI watch](https://marsanne.studio/en/ai-watch)

Announcement · 22 September 2026

# With €30 million, Biolevate wants to make AI a compliance tool for laboratories

Original title, in French: “Avec 30 millions d’euros, BIOLEVATE veut faire de l’IA un outil de conformité pour les laboratoires”

**Publication**

FrenchWeb (France)

**Author**

Unsigned

**Published on**

22 September 2026 · read in the page structured data

## Summary

Paris-based startup Biolevate has announced a €30 million Series A, co-led by RAISE France and Orange Ventures, to develop its AI dedicated to regulated operations in the healthcare industries. The company, which started in medical writing, is extending its use to research, clinical trials and regulatory dossiers, with agents that trace every claim back to its source. It reports more than ten large-account clients in production, partnerships with Sanofi, NVIDIA and Microsoft, literature reviews up to sixteen times faster and 80% efficiency gains in regulatory monitoring. Biolevate has 50 employees and plans to double its headcount, with the opening of an office in Boston.

Summary based on the full text of the article.

[Read the article on FrenchWeb →](https://www.frenchweb.fr/avec-30-millions-deuros-biolevate-veut-faire-de-lia-un-outil-de-conformite-pour-les-laboratoires/463589)

## Figures cited

-   30 EUR million
    
    amount of the Series A raised by Biolevate
    
    Biolevate, 2026
    
    > « La startup annonce une Série A de 30 millions d’euros, co-menée par RAISE France et Orange Ventures, avec la participation d’EQT Ventures, du MSD Global Health Innovation Fund et de Station F. »
    
-   6 EUR million
    
    amount of the previous seed round
    
    Biolevate, November 2024
    
    > « Elle avait levé 6 millions d’euros en amorçage en novembre 2024. »
    
-   16 multiplication factor
    
    speed-up of literature reviews through AI
    
    Biolevate clients
    
    > « Biolevate avance des revues de littérature réalisées jusqu’à seize fois plus vite »
    
-   80 %
    
    efficiency gains in regulatory monitoring and compliance
    
    Biolevate clients
    
    > « 80 % de gains d’efficacité dans la veille réglementaire et la conformité »
    
-   100,000 agents
    
    number of agents that can run simultaneously
    
    Biolevate platform
    
    > « communique sur la capacité de faire fonctionner 100 000 agents simultanément »
    
-   50 employees
    
    number of Biolevate employees
    
    Biolevate, 2026
    
    > « La startup compte désormais 50 collaborateurs, et prévoit de doubler de nouveau ses effectifs. »
    

## Classification

**Country**

France, United States

**Company size**

Large companies

**Industries**

Healthcare, pharmaceuticals, social care

**Companies**

IQVIA (cited), Sanofi (deploys AI), EQT Ventures (cited), Certara (cited), ArisGlobal (cited), STATION F (cited), Clarivate (cited), Orange Ventures (cited), RAISE France (cited), MSD Global Health Innovation Fund (cited), Indegene (cited), Biolevate (supplier), Yseop (cited), Microsoft (cited), Veeva (cited), Nvidia (cited)

**Keywords**

artificial intelligence, regulatory compliance, pharmaceutical industry, ai agents, fundraising, healthcare

Entry written by Marsanne Studio from the cited article, with the help of an AI model (claude-sonnet-5). The rights to the article and its illustrations belong to FrenchWeb. Entry translated from French by Claude Sonnet 5.5.